

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.26574353 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.26574353 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.79752331 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.62718311 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.62718311 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.62718311 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.62718311 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.62718311 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.62718311 |
| 10 | negative regulation of microtubule polymerization (GO:0031115) | 5.57241277 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 5.44597783 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41431158 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 5.15605254 |
| 14 | type I interferon signaling pathway (GO:0060337) | 5.04667158 |
| 15 | cellular response to type I interferon (GO:0071357) | 5.04667158 |
| 16 | response to type I interferon (GO:0034340) | 5.03437811 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.80763825 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.66769395 |
| 19 | response to interferon-alpha (GO:0035455) | 4.62891352 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.40616621 |
| 21 | response to peptidoglycan (GO:0032494) | 4.32899557 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.17754881 |
| 23 | DNA unwinding involved in DNA replication (GO:0006268) | 4.08906817 |
| 24 | positive regulation of interferon-beta production (GO:0032728) | 4.04353180 |
| 25 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.96452202 |
| 26 | gonadal mesoderm development (GO:0007506) | 3.92050953 |
| 27 | response to host immune response (GO:0052572) | 3.91960481 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.91960481 |
| 29 | cellular response to interferon-alpha (GO:0035457) | 3.87255206 |
| 30 | cellular response to interferon-beta (GO:0035458) | 3.84146816 |
| 31 | DNA strand elongation (GO:0022616) | 3.83720657 |
| 32 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.81406667 |
| 33 | response to interferon-beta (GO:0035456) | 3.80446577 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.76871471 |
| 35 | negative regulation of viral genome replication (GO:0045071) | 3.76824162 |
| 36 | GDP-mannose metabolic process (GO:0019673) | 3.73132655 |
| 37 | B cell mediated immunity (GO:0019724) | 3.67646025 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62350989 |
| 39 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.61901086 |
| 40 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.61517382 |
| 41 | folic acid metabolic process (GO:0046655) | 3.60307011 |
| 42 | T-helper 1 type immune response (GO:0042088) | 3.59334825 |
| 43 | response to host (GO:0075136) | 3.55546403 |
| 44 | response to host defenses (GO:0052200) | 3.55546403 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55546403 |
| 46 | cellular response to zinc ion (GO:0071294) | 3.54648208 |
| 47 | DNA replication initiation (GO:0006270) | 3.54165237 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52725991 |
| 49 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.52355111 |
| 50 | respiratory burst (GO:0045730) | 3.51124902 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.40282569 |
| 52 | granulocyte activation (GO:0036230) | 3.37659861 |
| 53 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.35409533 |
| 54 | natural killer cell mediated immunity (GO:0002228) | 3.32470193 |
| 55 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.32470193 |
| 56 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.31565548 |
| 57 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30082785 |
| 58 | cellular response to virus (GO:0098586) | 3.29065917 |
| 59 | proline biosynthetic process (GO:0006561) | 3.27811949 |
| 60 | regulation of RIG-I signaling pathway (GO:0039535) | 3.27362613 |
| 61 | cellular response to exogenous dsRNA (GO:0071360) | 3.27345419 |
| 62 | neutrophil activation (GO:0042119) | 3.25930805 |
| 63 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.22182451 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 3.22144357 |
| 65 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.21206876 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16474051 |
| 67 | snRNA metabolic process (GO:0016073) | 3.14550322 |
| 68 | NIK/NF-kappaB signaling (GO:0038061) | 3.14217641 |
| 69 | defense response to protozoan (GO:0042832) | 3.13070138 |
| 70 | microglial cell activation (GO:0001774) | 3.12866818 |
| 71 | response to muramyl dipeptide (GO:0032495) | 3.12807003 |
| 72 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11585214 |
| 73 | cellular response to interferon-gamma (GO:0071346) | 3.09090636 |
| 74 | mitotic chromosome condensation (GO:0007076) | 3.06156015 |
| 75 | regulation of interferon-beta production (GO:0032648) | 3.05404054 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.05162752 |
| 77 | positive regulation of prostaglandin secretion (GO:0032308) | 3.03984618 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.03896282 |
| 79 | positive regulation of interleukin-12 production (GO:0032735) | 3.01589591 |
| 80 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.99040637 |
| 81 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98325186 |
| 82 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.96625573 |
| 83 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96179623 |
| 84 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.95019593 |
| 85 | snRNA processing (GO:0016180) | 2.94512817 |
| 86 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94490927 |
| 87 | Golgi transport vesicle coating (GO:0048200) | 2.94154521 |
| 88 | COPI coating of Golgi vesicle (GO:0048205) | 2.94154521 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93437416 |
| 90 | defense response to virus (GO:0051607) | 2.92910254 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89205591 |
| 92 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.88898944 |
| 93 | reactive oxygen species biosynthetic process (GO:1903409) | 2.88025498 |
| 94 | response to interferon-gamma (GO:0034341) | 2.83808714 |
| 95 | myeloid dendritic cell differentiation (GO:0043011) | 2.83380443 |
| 96 | positive regulation of protein homooligomerization (GO:0032464) | 2.82616198 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 2.81850969 |
| 98 | macrophage activation (GO:0042116) | 2.79595484 |
| 99 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.78775208 |
| 100 | telomere maintenance via recombination (GO:0000722) | 2.76727071 |
| 101 | response to protozoan (GO:0001562) | 2.75921230 |
| 102 | leukocyte mediated cytotoxicity (GO:0001909) | 2.71642617 |
| 103 | I-kappaB phosphorylation (GO:0007252) | 2.69059212 |
| 104 | negative regulation of interleukin-17 production (GO:0032700) | 2.69038656 |
| 105 | myeloid dendritic cell activation (GO:0001773) | 2.68591133 |
| 106 | dendritic cell differentiation (GO:0097028) | 2.67431567 |
| 107 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.67300010 |
| 108 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.66498152 |
| 109 | regulation of growth of symbiont in host (GO:0044126) | 2.66498152 |
| 110 | negative regulation of growth of symbiont in host (GO:0044130) | 2.66498152 |
| 111 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.66498152 |
| 112 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.64232205 |
| 113 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.64178418 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 2.63436020 |
| 115 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.62579726 |
| 116 | regulation of translational fidelity (GO:0006450) | 2.62355766 |
| 117 | regulation of response to interferon-gamma (GO:0060330) | 2.62251100 |
| 118 | pinocytosis (GO:0006907) | 2.62099523 |
| 119 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.61943445 |
| 120 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61134130 |
| 121 | regulation of interleukin-12 production (GO:0032655) | 2.60474864 |
| 122 | T cell migration (GO:0072678) | 2.59395129 |
| 123 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59005123 |
| 124 | N-acetylneuraminate metabolic process (GO:0006054) | 2.56256671 |
| 125 | B cell receptor signaling pathway (GO:0050853) | 2.55816450 |
| 126 | glycosphingolipid catabolic process (GO:0046479) | 2.52800027 |
| 127 | tRNA methylation (GO:0030488) | 2.52227790 |
| 128 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.52063674 |
| 129 | mitochondrial fusion (GO:0008053) | 2.48724856 |
| 130 | regulation of mitochondrial translation (GO:0070129) | 2.48288722 |
| 131 | regulation of prostaglandin secretion (GO:0032306) | 2.47375812 |
| 132 | mitotic recombination (GO:0006312) | 2.46286840 |
| 133 | germinal center formation (GO:0002467) | 2.44597793 |
| 134 | mannose metabolic process (GO:0006013) | 2.42645960 |
| 135 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.41513556 |
| 136 | ceramide catabolic process (GO:0046514) | 2.41420731 |
| 137 | urea cycle (GO:0000050) | 2.41027909 |
| 138 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.39886374 |
| 139 | * chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.38569890 |
| 140 | ribosome biogenesis (GO:0042254) | 2.38533797 |
| 141 | amyloid precursor protein catabolic process (GO:0042987) | 2.38029334 |
| 142 | pseudouridine synthesis (GO:0001522) | 2.35874359 |
| 143 | citrulline biosynthetic process (GO:0019240) | 2.33328931 |
| 144 | formation of translation preinitiation complex (GO:0001731) | 2.32828284 |
| 145 | glycolipid catabolic process (GO:0019377) | 2.31981534 |
| 146 | negative regulation of B cell apoptotic process (GO:0002903) | 2.31199995 |
| 147 | regulation of chromatin binding (GO:0035561) | 2.30005860 |
| 148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.28927992 |
| 149 | regulation of protein heterodimerization activity (GO:0043497) | 2.27852081 |
| 150 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.27441788 |
| 151 | regulation of translation in response to stress (GO:0043555) | 2.26272492 |
| 152 | carnitine shuttle (GO:0006853) | 2.26184252 |
| 153 | DNA duplex unwinding (GO:0032508) | 2.25932034 |
| 154 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.25087736 |
| 155 | nucleobase biosynthetic process (GO:0046112) | 2.21677814 |
| 156 | B cell homeostasis (GO:0001782) | 2.20045438 |
| 157 | nuclear pore complex assembly (GO:0051292) | 2.18990931 |
| 158 | T cell apoptotic process (GO:0070231) | 2.17801824 |
| 159 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.17581911 |
| 160 | myeloid cell homeostasis (GO:0002262) | 2.17521154 |
| 161 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.16511228 |
| 162 | regulation of histone H3-K27 methylation (GO:0061085) | 2.15304094 |
| 163 | nitric oxide biosynthetic process (GO:0006809) | 2.15218832 |
| 164 | DNA geometric change (GO:0032392) | 2.13609365 |
| 165 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.13607813 |
| 166 | pyrimidine nucleoside salvage (GO:0043097) | 2.13067109 |
| 167 | pyrimidine-containing compound salvage (GO:0008655) | 2.13067109 |
| 168 | regulation of B cell apoptotic process (GO:0002902) | 2.11867455 |
| 169 | rRNA modification (GO:0000154) | 2.11325112 |
| 170 | dosage compensation (GO:0007549) | 2.11232880 |
| 171 | tRNA modification (GO:0006400) | 2.10668517 |
| 172 | base-excision repair (GO:0006284) | 2.10565656 |
| 173 | pentose-phosphate shunt (GO:0006098) | 2.10280664 |
| 174 | urea metabolic process (GO:0019627) | 2.09996140 |
| 175 | positive regulation of protein oligomerization (GO:0032461) | 2.09086680 |
| 176 | mitotic nuclear envelope disassembly (GO:0007077) | 2.08241337 |
| 177 | folic acid-containing compound metabolic process (GO:0006760) | 2.07807843 |
| 178 | DNA replication checkpoint (GO:0000076) | 2.07343291 |
| 179 | cellular response to arsenic-containing substance (GO:0071243) | 2.06558007 |
| 180 | deoxyribonucleotide catabolic process (GO:0009264) | 2.06419601 |
| 181 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.05338298 |
| 182 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.04160819 |
| 183 | pentose metabolic process (GO:0019321) | 2.03723593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.91830634 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.81867650 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.68678242 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.37040325 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.56784753 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54445750 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.44935508 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12566234 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10489302 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91108563 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82985428 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71295205 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67232236 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.59443332 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55187610 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47342821 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.47033235 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27258687 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.21214853 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18968289 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18831491 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.16650300 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.12584262 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07809843 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05762453 |
| 26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.04373760 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.00166105 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96620863 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94521292 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91723183 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89103060 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.88866474 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84025361 |
| 34 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.83390484 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.82565547 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.79384852 |
| 37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.77710221 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.76320572 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75832055 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.68845568 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67715393 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66685687 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65844813 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64633127 |
| 45 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64547043 |
| 46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.63135657 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60216584 |
| 48 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.60166494 |
| 49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59520546 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.59035421 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54820984 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53494029 |
| 53 | * MYB_26560356_Chip-Seq_TH1_Human | 1.53204904 |
| 54 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52883355 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51447512 |
| 56 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48524707 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48460188 |
| 58 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.46991787 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44887061 |
| 60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.44122531 |
| 61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.43936529 |
| 62 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42235717 |
| 63 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.41455678 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.41445696 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39308172 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38420047 |
| 67 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.38256987 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 1.37625473 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35579818 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35051960 |
| 71 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33549101 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31635340 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31365209 |
| 74 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.30987871 |
| 75 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.30668940 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30046546 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28849155 |
| 78 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28725360 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28711482 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28482030 |
| 81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25026831 |
| 82 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23013790 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23008862 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22633906 |
| 85 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22592196 |
| 86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.21939638 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21581511 |
| 88 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.21431567 |
| 89 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21170909 |
| 90 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21082868 |
| 91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20856921 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20665499 |
| 93 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.20471925 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19790355 |
| 95 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19301662 |
| 96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16739113 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16424282 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15165061 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15095835 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14749899 |
| 101 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.14499227 |
| 102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14174249 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13708735 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13512371 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10282838 |
| 106 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09586426 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09300512 |
| 108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08913999 |
| 109 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08506612 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08382930 |
| 111 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08253557 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07693945 |
| 113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07521870 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07467312 |
| 115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07063177 |
| 116 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06916661 |
| 117 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04882749 |
| 118 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03648945 |
| 119 | MAF_26560356_Chip-Seq_TH2_Human | 1.02998690 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02686445 |
| 121 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01463094 |
| 122 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01320306 |
| 123 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99134150 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98883862 |
| 125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97548359 |
| 126 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96970486 |
| 127 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94787014 |
| 128 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91894011 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89688308 |
| 130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87489390 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86682872 |
| 132 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86381484 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84916841 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83910177 |
| 135 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82993738 |
| 136 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82787445 |
| 137 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81975313 |
| 138 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80530314 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.79329217 |
| 140 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79243731 |
| 141 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.78370840 |
| 142 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77955975 |
| 143 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77234172 |
| 144 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76400612 |
| 145 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76168061 |
| 146 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75268765 |
| 147 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75078448 |
| 148 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74912928 |
| 149 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74912928 |
| 150 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.73777516 |
| 151 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.73652279 |
| 152 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.73469059 |
| 153 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72683059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.27987979 |
| 2 | MP0009785_altered_susceptibility_to | 3.55299822 |
| 3 | MP0003436_decreased_susceptibility_to | 3.19881994 |
| 4 | MP0003303_peritoneal_inflammation | 3.01707382 |
| 5 | MP0005451_abnormal_body_composition | 2.88623116 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.84026924 |
| 7 | MP0000685_abnormal_immune_system | 2.82529467 |
| 8 | MP0003724_increased_susceptibility_to | 2.79428582 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.78889161 |
| 10 | MP0005387_immune_system_phenotype | 2.78681483 |
| 11 | MP0001790_abnormal_immune_system | 2.78681483 |
| 12 | MP0005025_abnormal_response_to | 2.74725043 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.73734389 |
| 14 | MP0002419_abnormal_innate_immunity | 2.67000401 |
| 15 | MP0006082_CNS_inflammation | 2.64805880 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.64079498 |
| 17 | MP0008057_abnormal_DNA_replication | 2.46236014 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.44972796 |
| 19 | MP0001800_abnormal_humoral_immune | 2.39414004 |
| 20 | MP0005671_abnormal_response_to | 2.37351225 |
| 21 | MP0002723_abnormal_immune_serum | 2.29956613 |
| 22 | MP0003111_abnormal_nucleus_morphology | 2.23164321 |
| 23 | MP0003693_abnormal_embryo_hatching | 2.20320599 |
| 24 | MP0001661_extended_life_span | 2.09931923 |
| 25 | MP0001819_abnormal_immune_cell | 2.06592386 |
| 26 | MP0004510_myositis | 2.04510496 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.04178459 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.03826404 |
| 29 | MP0003172_abnormal_lysosome_physiology | 2.01379694 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.94105942 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.92642068 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.92011232 |
| 33 | MP0004947_skin_inflammation | 1.89705954 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.86730742 |
| 35 | MP0003077_abnormal_cell_cycle | 1.83673251 |
| 36 | MP0002006_tumorigenesis | 1.77317738 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.76866050 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.73219723 |
| 39 | MP0001853_heart_inflammation | 1.70672281 |
| 40 | MP0003448_altered_tumor_morphology | 1.70576076 |
| 41 | MP0008058_abnormal_DNA_repair | 1.70092960 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.67270046 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.66757608 |
| 44 | MP0009840_abnormal_foam_cell | 1.63801316 |
| 45 | MP0002405_respiratory_system_inflammati | 1.62649081 |
| 46 | MP0008469_abnormal_protein_level | 1.59778689 |
| 47 | MP0000858_altered_metastatic_potential | 1.58520531 |
| 48 | MP0002009_preneoplasia | 1.58261777 |
| 49 | MP0000716_abnormal_immune_system | 1.58032556 |
| 50 | MP0000343_altered_response_to | 1.57143407 |
| 51 | MP0002398_abnormal_bone_marrow | 1.53577082 |
| 52 | MP0009764_decreased_sensitivity_to | 1.52447822 |
| 53 | MP0004233_abnormal_muscle_weight | 1.49055792 |
| 54 | MP0010307_abnormal_tumor_latency | 1.45692124 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.45140010 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.44007384 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 1.39868120 |
| 58 | MP0005083_abnormal_biliary_tract | 1.38228994 |
| 59 | MP0009278_abnormal_bone_marrow | 1.36738935 |
| 60 | MP0005310_abnormal_salivary_gland | 1.35426560 |
| 61 | MP0003786_premature_aging | 1.34781074 |
| 62 | MP0003075_altered_response_to | 1.32858651 |
| 63 | MP0002429_abnormal_blood_cell | 1.32173970 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 1.31471747 |
| 65 | MP0001958_emphysema | 1.31443559 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.30938970 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.30792983 |
| 68 | MP0006054_spinal_hemorrhage | 1.28349259 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.28187370 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.26992199 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.25559122 |
| 72 | MP0001545_abnormal_hematopoietic_system | 1.25559122 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 1.25550559 |
| 74 | MP0000747_muscle_weakness | 1.24692656 |
| 75 | MP0009697_abnormal_copulation | 1.23297786 |
| 76 | MP0002722_abnormal_immune_system | 1.21675718 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 1.20256271 |
| 78 | MP0002163_abnormal_gland_morphology | 1.18878720 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 1.18581734 |
| 80 | MP0008007_abnormal_cellular_replicative | 1.17095353 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 1.16492348 |
| 82 | MP0002933_joint_inflammation | 1.14828614 |
| 83 | MP0000313_abnormal_cell_death | 1.13746220 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 1.11146061 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.09664385 |
| 86 | MP0008260_abnormal_autophagy | 1.09242003 |
| 87 | MP0005023_abnormal_wound_healing | 1.08611186 |
| 88 | MP0003763_abnormal_thymus_physiology | 1.08062533 |
| 89 | MP0005390_skeleton_phenotype | 1.07703721 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 1.06411384 |
| 91 | MP0003183_abnormal_peptide_metabolism | 1.03885279 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 1.02864031 |
| 93 | MP0002254_reproductive_system_inflammat | 1.02329857 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 1.00404445 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 0.98045730 |
| 96 | MP0000350_abnormal_cell_proliferation | 0.97774012 |
| 97 | MP0003186_abnormal_redox_activity | 0.97270072 |
| 98 | MP0003091_abnormal_cell_migration | 0.97213721 |
| 99 | MP0000604_amyloidosis | 0.96650341 |
| 100 | MP0000490_abnormal_crypts_of | 0.96648961 |
| 101 | MP0005164_abnormal_response_to | 0.96002343 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.95034458 |
| 103 | MP0001873_stomach_inflammation | 0.94352458 |
| 104 | MP0002396_abnormal_hematopoietic_system | 0.93529530 |
| 105 | MP0005166_decreased_susceptibility_to | 0.92615722 |
| 106 | MP0000358_abnormal_cell_content/ | 0.92489501 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.92327270 |
| 108 | MP0005330_cardiomyopathy | 0.90734819 |
| 109 | MP0009763_increased_sensitivity_to | 0.90535466 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90035704 |
| 111 | MP0008932_abnormal_embryonic_tissue | 0.89828225 |
| 112 | MP0001730_embryonic_growth_arrest | 0.88639813 |
| 113 | MP0000609_abnormal_liver_physiology | 0.86770038 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.85733878 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.82581716 |
| 116 | MP0001851_eye_inflammation | 0.81930041 |
| 117 | MP0000249_abnormal_blood_vessel | 0.81364225 |
| 118 | MP0003279_aneurysm | 0.80973485 |
| 119 | MP0005275_abnormal_skin_tensile | 0.79856984 |
| 120 | MP0003795_abnormal_bone_structure | 0.79080403 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.78112250 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.77009774 |
| 123 | MP0005501_abnormal_skin_physiology | 0.75187845 |
| 124 | MP0003828_pulmonary_edema | 0.75097762 |
| 125 | MP0004858_abnormal_nervous_system | 0.75092197 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.74965233 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.74396756 |
| 128 | MP0000750_abnormal_muscle_regeneration | 0.73833996 |
| 129 | MP0003646_muscle_fatigue | 0.73476214 |
| 130 | MP0001727_abnormal_embryo_implantation | 0.73475372 |
| 131 | MP0002136_abnormal_kidney_physiology | 0.70668268 |
| 132 | MP0001879_abnormal_lymphatic_vessel | 0.70099574 |
| 133 | MP0000703_abnormal_thymus_morphology | 0.69095982 |
| 134 | MP0003045_fibrosis | 0.69089433 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.67502400 |
| 136 | MP0005174_abnormal_tail_pigmentation | 0.66240183 |
| 137 | MP0002019_abnormal_tumor_incidence | 0.65953700 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.65543591 |
| 139 | MP0000371_diluted_coat_color | 0.65061106 |
| 140 | MP0003866_abnormal_defecation | 0.64495904 |
| 141 | MP0002277_abnormal_respiratory_mucosa | 0.63663892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.59934709 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.50548300 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.02734677 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.80643953 |
| 5 | Chronic otitis media (HP:0000389) | 4.44999522 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.39318461 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.23454149 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.15736947 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.06333014 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.99575389 |
| 11 | Myositis (HP:0100614) | 3.95292790 |
| 12 | Agammaglobulinemia (HP:0004432) | 3.90673241 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 3.75489048 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.73444343 |
| 15 | Interstitial pulmonary disease (HP:0006530) | 3.71948334 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.59238190 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.47745981 |
| 18 | Basal ganglia calcification (HP:0002135) | 3.44561586 |
| 19 | Progressive muscle weakness (HP:0003323) | 3.42852334 |
| 20 | Orchitis (HP:0100796) | 3.40594321 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 3.37733488 |
| 22 | Nasal polyposis (HP:0100582) | 3.35049873 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.34423516 |
| 24 | Recurrent viral infections (HP:0004429) | 3.33512977 |
| 25 | Recurrent skin infections (HP:0001581) | 3.26866226 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.18984919 |
| 27 | Vasculitis (HP:0002633) | 3.17854902 |
| 28 | Gingivitis (HP:0000230) | 3.14805290 |
| 29 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.12189837 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.10555039 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.10555039 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.06389653 |
| 33 | Microvesicular hepatic steatosis (HP:0001414) | 3.05033412 |
| 34 | Cellulitis (HP:0100658) | 2.97706677 |
| 35 | Hematochezia (HP:0002573) | 2.97082636 |
| 36 | Chromsome breakage (HP:0040012) | 2.94681812 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83830281 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83830281 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83830281 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76320417 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76320417 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76320417 |
| 43 | Tetraparesis (HP:0002273) | 2.76090996 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 2.72507632 |
| 45 | Obstructive lung disease (HP:0006536) | 2.69901533 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69901533 |
| 47 | Thrombocytosis (HP:0001894) | 2.67527522 |
| 48 | Increased IgM level (HP:0003496) | 2.67260416 |
| 49 | Cervical subluxation (HP:0003308) | 2.67208098 |
| 50 | Optic neuritis (HP:0100653) | 2.66828077 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.66828077 |
| 52 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.66434804 |
| 53 | Emphysema (HP:0002097) | 2.65391015 |
| 54 | Stomatitis (HP:0010280) | 2.65043291 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.64417062 |
| 56 | Myoglobinuria (HP:0002913) | 2.61231119 |
| 57 | Poikiloderma (HP:0001029) | 2.59045606 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.57548744 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.55501274 |
| 60 | Pustule (HP:0200039) | 2.54417981 |
| 61 | Periodontitis (HP:0000704) | 2.51548543 |
| 62 | Esophageal neoplasm (HP:0100751) | 2.50089734 |
| 63 | Neoplasm of head and neck (HP:0012288) | 2.50089734 |
| 64 | Chronic sinusitis (HP:0011109) | 2.48643731 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.47496337 |
| 66 | Loss of speech (HP:0002371) | 2.44050532 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43770583 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43770583 |
| 69 | Rhabdomyolysis (HP:0003201) | 2.43095163 |
| 70 | Osteomyelitis (HP:0002754) | 2.41985494 |
| 71 | Testicular atrophy (HP:0000029) | 2.39759392 |
| 72 | Hyperammonemia (HP:0001987) | 2.38804068 |
| 73 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.38192460 |
| 74 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.38192460 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.38192460 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.38192460 |
| 77 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37424713 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 2.37424713 |
| 79 | Thoracic kyphosis (HP:0002942) | 2.36764525 |
| 80 | Hypokinesia (HP:0002375) | 2.35048872 |
| 81 | Disinhibition (HP:0000734) | 2.33310019 |
| 82 | Axonal loss (HP:0003447) | 2.32707452 |
| 83 | Poor head control (HP:0002421) | 2.32506228 |
| 84 | Hypertensive crisis (HP:0100735) | 2.31861635 |
| 85 | Urticaria (HP:0001025) | 2.27268941 |
| 86 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25271851 |
| 87 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.25094207 |
| 88 | Villous atrophy (HP:0011473) | 2.25094207 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 2.24128734 |
| 90 | Petechiae (HP:0000967) | 2.23224962 |
| 91 | Gastrointestinal infarctions (HP:0005244) | 2.22462199 |
| 92 | Colitis (HP:0002583) | 2.21895668 |
| 93 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21861404 |
| 94 | Squamous cell carcinoma (HP:0002860) | 2.21713969 |
| 95 | Arterial thrombosis (HP:0004420) | 2.20960503 |
| 96 | Hemoptysis (HP:0002105) | 2.18581199 |
| 97 | Meningitis (HP:0001287) | 2.17471341 |
| 98 | Spontaneous hematomas (HP:0007420) | 2.16224836 |
| 99 | Peritonitis (HP:0002586) | 2.15585049 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15036400 |
| 101 | IgA deficiency (HP:0002720) | 2.14008758 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 2.13300290 |
| 103 | Increased IgE level (HP:0003212) | 2.13114532 |
| 104 | Recurrent pneumonia (HP:0006532) | 2.12740870 |
| 105 | Abnormality of T cell physiology (HP:0011840) | 2.12171193 |
| 106 | Myopathic facies (HP:0002058) | 2.10878630 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09549879 |
| 108 | Myocardial infarction (HP:0001658) | 2.09492898 |
| 109 | Skin ulcer (HP:0200042) | 2.08100110 |
| 110 | Leukocytosis (HP:0001974) | 2.07904632 |
| 111 | Fatigue (HP:0012378) | 2.07027161 |
| 112 | Abnormal gallbladder physiology (HP:0012438) | 2.06678460 |
| 113 | Cholecystitis (HP:0001082) | 2.06678460 |
| 114 | Progressive external ophthalmoplegia (HP:0000590) | 2.06514985 |
| 115 | Porencephaly (HP:0002132) | 2.05888177 |
| 116 | Inflammation of the large intestine (HP:0002037) | 2.05587737 |
| 117 | Glomerulonephritis (HP:0000099) | 2.04393057 |
| 118 | Exercise-induced myalgia (HP:0003738) | 2.04056319 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 2.03848445 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 2.03359006 |
| 121 | Premature loss of primary teeth (HP:0006323) | 2.03284227 |
| 122 | Hepatosplenomegaly (HP:0001433) | 2.02632678 |
| 123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02061115 |
| 124 | Increased serum ferritin (HP:0003281) | 2.01656715 |
| 125 | Leukopenia (HP:0001882) | 2.00848573 |
| 126 | Gingival bleeding (HP:0000225) | 2.00523067 |
| 127 | Cheilitis (HP:0100825) | 1.99068237 |
| 128 | Autoimmune hemolytic anemia (HP:0001890) | 1.98483838 |
| 129 | Recurrent sinusitis (HP:0011108) | 1.98447383 |
| 130 | Multiple enchondromatosis (HP:0005701) | 1.98231270 |
| 131 | Abnormality of the pericardium (HP:0001697) | 1.95355901 |
| 132 | Chest pain (HP:0100749) | 1.94738498 |
| 133 | Chronic diarrhea (HP:0002028) | 1.94625401 |
| 134 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94357368 |
| 135 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94178038 |
| 136 | Restrictive lung disease (HP:0002091) | 1.93858923 |
| 137 | Paralysis (HP:0003470) | 1.92593345 |
| 138 | Abnormality of T cells (HP:0002843) | 1.92344733 |
| 139 | Lymphopenia (HP:0001888) | 1.92050029 |
| 140 | Agnosia (HP:0010524) | 1.90923522 |
| 141 | Rough bone trabeculation (HP:0100670) | 1.89832919 |
| 142 | Nephritis (HP:0000123) | 1.89668491 |
| 143 | Eosinophilia (HP:0001880) | 1.89025654 |
| 144 | Hemorrhage of the eye (HP:0011885) | 1.87469151 |
| 145 | Malnutrition (HP:0004395) | 1.86932260 |
| 146 | Cardiomegaly (HP:0001640) | 1.86931901 |
| 147 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.86858191 |
| 148 | Thick nail (HP:0001805) | 1.86820402 |
| 149 | Alkalosis (HP:0001948) | 1.86134686 |
| 150 | Viral hepatitis (HP:0006562) | 1.85138383 |
| 151 | J-shaped sella turcica (HP:0002680) | 1.82666517 |
| 152 | Entropion (HP:0000621) | 1.82154475 |
| 153 | Skin rash (HP:0000988) | 1.82129307 |
| 154 | Bone pain (HP:0002653) | 1.81579180 |
| 155 | Hypergonadotropic hypogonadism (HP:0000815) | 1.80242753 |
| 156 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.78274125 |
| 157 | Lymphoma (HP:0002665) | 1.76949318 |
| 158 | IgM deficiency (HP:0002850) | 1.74510394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 3.66673374 |
| 2 | TBK1 | 3.64626688 |
| 3 | ERN1 | 3.64588662 |
| 4 | MAP3K14 | 2.97950711 |
| 5 | PDK2 | 2.95625359 |
| 6 | SMG1 | 2.92742736 |
| 7 | BLK | 2.92481596 |
| 8 | JAK3 | 2.88803990 |
| 9 | KIT | 2.79398188 |
| 10 | IKBKE | 2.77063956 |
| 11 | MAP4K1 | 2.71886127 |
| 12 | IRAK4 | 2.55663896 |
| 13 | IRAK3 | 2.54620469 |
| 14 | JAK1 | 2.39271965 |
| 15 | PRPF4B | 2.38217933 |
| 16 | PIM2 | 2.32372712 |
| 17 | RIPK4 | 2.04991760 |
| 18 | IKBKB | 2.00376195 |
| 19 | MAPKAPK3 | 1.86522422 |
| 20 | RPS6KA4 | 1.85185952 |
| 21 | FGFR4 | 1.83863028 |
| 22 | TGFBR2 | 1.79797035 |
| 23 | RPS6KB2 | 1.71142670 |
| 24 | MAP2K7 | 1.69613561 |
| 25 | ZAP70 | 1.66911100 |
| 26 | CDC7 | 1.66664361 |
| 27 | TESK2 | 1.65442891 |
| 28 | NME2 | 1.60983438 |
| 29 | TRIB3 | 1.58933263 |
| 30 | STK10 | 1.57446808 |
| 31 | WNK4 | 1.56925587 |
| 32 | EPHB1 | 1.46733123 |
| 33 | PBK | 1.46253941 |
| 34 | CSF1R | 1.43735595 |
| 35 | CSK | 1.40095253 |
| 36 | BTK | 1.36777541 |
| 37 | TAOK3 | 1.34976430 |
| 38 | LRRK2 | 1.32369944 |
| 39 | KDR | 1.31785036 |
| 40 | MAP3K13 | 1.31505989 |
| 41 | MAP2K2 | 1.30880592 |
| 42 | MST1R | 1.29106633 |
| 43 | FLT3 | 1.28969112 |
| 44 | NEK9 | 1.28287358 |
| 45 | SYK | 1.26551606 |
| 46 | CHUK | 1.25345354 |
| 47 | TXK | 1.21896606 |
| 48 | FGFR3 | 1.18753950 |
| 49 | SCYL2 | 1.16557103 |
| 50 | HCK | 1.13187145 |
| 51 | VRK2 | 1.09800159 |
| 52 | EPHA3 | 1.08359233 |
| 53 | PKN2 | 1.07601568 |
| 54 | MATK | 1.07394444 |
| 55 | TEC | 1.07147053 |
| 56 | BCKDK | 1.06388180 |
| 57 | MAP3K10 | 1.06355496 |
| 58 | CHEK2 | 1.02719218 |
| 59 | ZAK | 1.02213743 |
| 60 | PTK6 | 1.01780060 |
| 61 | JAK2 | 1.00568078 |
| 62 | TTN | 0.98997407 |
| 63 | MAP2K3 | 0.98271323 |
| 64 | STK39 | 0.98177102 |
| 65 | PIM1 | 0.98077642 |
| 66 | LYN | 0.97666045 |
| 67 | CDK7 | 0.97299494 |
| 68 | LCK | 0.95212872 |
| 69 | TAOK2 | 0.84257372 |
| 70 | RIPK1 | 0.83521002 |
| 71 | MAP3K4 | 0.81630389 |
| 72 | PDPK1 | 0.81045890 |
| 73 | BUB1 | 0.78818959 |
| 74 | TLK1 | 0.78600233 |
| 75 | PAK4 | 0.78490008 |
| 76 | AURKA | 0.78299030 |
| 77 | ICK | 0.77230709 |
| 78 | ARAF | 0.76706111 |
| 79 | MARK3 | 0.74894307 |
| 80 | BMX | 0.74455518 |
| 81 | MAPK12 | 0.73559096 |
| 82 | ATR | 0.72036346 |
| 83 | ABL2 | 0.71770655 |
| 84 | EIF2AK2 | 0.70690731 |
| 85 | IRAK1 | 0.69442000 |
| 86 | TESK1 | 0.68840003 |
| 87 | MOS | 0.68645452 |
| 88 | MAP3K3 | 0.67757049 |
| 89 | OXSR1 | 0.65715407 |
| 90 | MST4 | 0.64135225 |
| 91 | FES | 0.62757081 |
| 92 | CDK8 | 0.62601128 |
| 93 | MAP3K5 | 0.61191292 |
| 94 | TGFBR1 | 0.61164083 |
| 95 | MAP2K4 | 0.61155205 |
| 96 | TTK | 0.59467471 |
| 97 | IRAK2 | 0.58647598 |
| 98 | MELK | 0.58130294 |
| 99 | CCNB1 | 0.58001440 |
| 100 | ITK | 0.57678438 |
| 101 | MAPKAPK5 | 0.57175588 |
| 102 | NEK6 | 0.56772986 |
| 103 | STK4 | 0.56094018 |
| 104 | SIK2 | 0.55692056 |
| 105 | EGFR | 0.55536759 |
| 106 | PRKCI | 0.54859585 |
| 107 | BRAF | 0.54394183 |
| 108 | STK3 | 0.54281808 |
| 109 | MTOR | 0.54200681 |
| 110 | HIPK2 | 0.53779952 |
| 111 | CDK9 | 0.53752482 |
| 112 | PRKCD | 0.53547067 |
| 113 | AURKB | 0.52920722 |
| 114 | MAP3K8 | 0.52516798 |
| 115 | ABL1 | 0.51438031 |
| 116 | NME1 | 0.51196375 |
| 117 | PDK1 | 0.50885802 |
| 118 | NLK | 0.50702538 |
| 119 | SIK3 | 0.48282051 |
| 120 | FGR | 0.48087692 |
| 121 | EPHA2 | 0.47553789 |
| 122 | CHEK1 | 0.46278872 |
| 123 | RPS6KA2 | 0.45983529 |
| 124 | MAPK7 | 0.44857179 |
| 125 | SRPK1 | 0.43514773 |
| 126 | EIF2AK3 | 0.43060246 |
| 127 | TRPM7 | 0.42200464 |
| 128 | GRK6 | 0.41443854 |
| 129 | MAP3K11 | 0.41235811 |
| 130 | CDK6 | 0.39509418 |
| 131 | MAPKAPK2 | 0.39021331 |
| 132 | PRKG2 | 0.37888341 |
| 133 | MAP3K1 | 0.37772044 |
| 134 | CAMK1D | 0.37326010 |
| 135 | CDK12 | 0.37050241 |
| 136 | CDK4 | 0.37016411 |
| 137 | SIK1 | 0.36220303 |
| 138 | EIF2AK1 | 0.34916199 |
| 139 | RPS6KA6 | 0.34648235 |
| 140 | RPS6KA5 | 0.33544847 |
| 141 | PASK | 0.31515525 |
| 142 | MAPK11 | 0.30858259 |
| 143 | CAMKK2 | 0.29434612 |
| 144 | DAPK3 | 0.28785925 |
| 145 | ALK | 0.28250309 |
| 146 | EEF2K | 0.27611229 |
| 147 | PDGFRA | 0.26651143 |
| 148 | PIK3CG | 0.25175990 |
| 149 | TIE1 | 0.24982267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16195236 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.80448100 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.75363262 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55563575 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.53841229 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.47378927 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.38708431 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.30373976 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.29683904 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17407488 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.14125429 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.13247269 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.11636686 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.11530047 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09401742 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.08535567 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 2.05234188 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94947665 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.92086304 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91784273 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.90275978 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89862501 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.89754396 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.89451667 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84478585 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.79620520 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.79034322 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77164589 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75809409 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 1.74131701 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67006735 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.55610665 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.50303893 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49995778 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48741402 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45895684 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44947519 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40921615 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40264210 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40205929 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.37144911 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.36968513 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35481300 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32867093 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.31970425 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.30680070 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.28483466 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.27606226 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.27087908 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27021883 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26992410 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 1.26465493 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25966020 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25366556 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 1.21110108 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20285702 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19138935 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18122291 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15769337 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11214504 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10780810 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08824644 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05916559 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05684272 |
| 65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95779989 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94797406 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93879238 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91294312 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.87488397 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87265363 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86856959 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80927214 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79399375 |
| 74 | RNA transport_Homo sapiens_hsa03013 | 0.79009873 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78469069 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76856897 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76855514 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76653164 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76062076 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73722784 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72997119 |
| 82 | Proteasome_Homo sapiens_hsa03050 | 0.72595204 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72535116 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71327025 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70935388 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69668504 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69411740 |
| 88 | Spliceosome_Homo sapiens_hsa03040 | 0.68672718 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65277991 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62157821 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.61752755 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61383665 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60264112 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59087991 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58378402 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57351711 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56482326 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56320272 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55528528 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54786246 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54519930 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.54175789 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53542174 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53263668 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52835812 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52625249 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50717987 |
| 108 | DNA replication_Homo sapiens_hsa03030 | 0.49556883 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48404112 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.47943463 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42811576 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42336332 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41929939 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40691299 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.40254622 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.39982241 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38248947 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38238655 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38209046 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38190553 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35623863 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35162244 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.33515839 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33510012 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32643002 |
| 126 | Protein export_Homo sapiens_hsa03060 | 0.30998448 |
| 127 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30564977 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29270952 |
| 129 | Base excision repair_Homo sapiens_hsa03410 | 0.28520067 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27255492 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26938437 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26865326 |
| 133 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26407051 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25323428 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24726401 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.24435212 |
| 137 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23489579 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.22599084 |
| 139 | Adherens junction_Homo sapiens_hsa04520 | 0.21553474 |

